172 related articles for article (PubMed ID: 10406496)
1. Pharmacological modulation of AGEs: a unique role for redox-active metal ions.
Weiss MF; Saxena AK; Monnier VM
Perit Dial Int; 1999; 19 Suppl 2():S62-7. PubMed ID: 10406496
[No Abstract] [Full Text] [Related]
2. Exogenous uptake of carbonyl stress compounds promoting AGE formation from peritoneal dialysis fluids.
Wieslander A; Linden T; Musi B; Järkelid L; Speidel R; Beck W; Henle T; Deppisch R
Contrib Nephrol; 2001; (131):82-9. PubMed ID: 11125566
[No Abstract] [Full Text] [Related]
3. Pathophysiology of the oxidative stress and its implication in uremia and dialysis.
Galli F; Canestrari F; Bellomo G
Contrib Nephrol; 1999; 127():1-31. PubMed ID: 10629773
[No Abstract] [Full Text] [Related]
4. Advanced glycation in uraemic toxicity.
van Ypersele de Strihou C
EDTNA ERCA J; 2003; 29(3):148-50. PubMed ID: 14552090
[TBL] [Abstract][Full Text] [Related]
5. Alterations of non-enzymatic biochemistry in uremia, diabetes, and atherosclerosis ("carbonyl stress").
Miyata T
Bull Mem Acad R Med Belg; 2002; 157(3-4):189-96; discussion 196-8. PubMed ID: 12508715
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic role of advanced glycation end-products (AGEs): an overview.
Weiss MF
Perit Dial Int; 1999; 19 Suppl 2():S47-52. PubMed ID: 10406493
[No Abstract] [Full Text] [Related]
7. Mechanisms for the formation of glycoxidation products in end-stage renal disease.
Weiss MF; Erhard P; Kader-Attia FA; Wu YC; Deoreo PB; Araki A; Glomb MA; Monnier VM
Kidney Int; 2000 Jun; 57(6):2571-85. PubMed ID: 10844627
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism.
Miyata T; Kurokawa K; VAN Ypersele DE Strihou C
J Am Soc Nephrol; 2000 Sep; 11(9):1744-1752. PubMed ID: 10966500
[No Abstract] [Full Text] [Related]
9. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
[TBL] [Abstract][Full Text] [Related]
10. Carbonyl stress: increased carbonyl modification of tissue and cellular proteins in uremia.
Miyata T; Izuhara Y; Sakai H; Kurokawa K
Perit Dial Int; 1999; 19 Suppl 2():S58-61. PubMed ID: 10406495
[TBL] [Abstract][Full Text] [Related]
11. Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia.
Witko-Sarsat V; Nguyen-Khoa T; Jungers P; Drüeke TB; Descamps-Latscha B
Nephrol Dial Transplant; 1999; 14 Suppl 1():76-8. PubMed ID: 10048460
[No Abstract] [Full Text] [Related]
12. Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity.
Miyata T; Saito A; Kurokawa K; van Ypersele de Strihou C
Nephrol Dial Transplant; 2001; 16 Suppl 4():8-11. PubMed ID: 11402090
[TBL] [Abstract][Full Text] [Related]
13. Measurement of protein glycation, glycated peptides, and glycation free adducts.
Thornalley PJ
Perit Dial Int; 2005; 25(6):522-33. PubMed ID: 16419322
[TBL] [Abstract][Full Text] [Related]
14. Decreased formation of advanced glycation end-products in peritoneal fluid by carnosine and related peptides.
Alhamdani MS; Al-Azzawie HF; Abbas FK
Perit Dial Int; 2007; 27(1):86-9. PubMed ID: 17179517
[TBL] [Abstract][Full Text] [Related]
15. Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients.
Uribarri J; Peppa M; Cai W; Goldberg T; Lu M; Baliga S; Vassalotti JA; Vlassara H
Am J Kidney Dis; 2003 Sep; 42(3):532-8. PubMed ID: 12955681
[TBL] [Abstract][Full Text] [Related]
16. Chelating activity of advanced glycation end-product inhibitors.
Price DL; Rhett PM; Thorpe SR; Baynes JW
J Biol Chem; 2001 Dec; 276(52):48967-72. PubMed ID: 11677237
[TBL] [Abstract][Full Text] [Related]
17. Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins.
Fu S; Fu MX; Baynes JW; Thorpe SR; Dean RT
Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):233-9. PubMed ID: 9461515
[TBL] [Abstract][Full Text] [Related]
18. Profound mishandling of protein glycation degradation products in uremia and dialysis.
Agalou S; Ahmed N; Babaei-Jadidi R; Dawnay A; Thornalley PJ
J Am Soc Nephrol; 2005 May; 16(5):1471-85. PubMed ID: 15800128
[TBL] [Abstract][Full Text] [Related]
19. Relevance of oxidative and carbonyl stress to long-term uremic complications.
Miyata T; Kurokawa K; van Ypersele de Strihou C
Kidney Int Suppl; 2000 Aug; 76():S120-5. PubMed ID: 10936808
[TBL] [Abstract][Full Text] [Related]
20. Changes in glycation and oxidation markers in patients starting peritoneal dialysis: a pilot study.
Boulanger E; Moranne O; Wautier MP; Witko-Sarsat V; Descamps-Latscha B; Kandoussi A; Grossin N; Wautier JL
Perit Dial Int; 2006; 26(2):207-12. PubMed ID: 16623427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
